Core Scientific, Inc.
CORZ
$19.57
-$0.21-1.06%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 308.34% | 91.42% | -11.89% | -42.37% | -40.66% |
| Total Other Revenue | -45.53% | -41.06% | -43.92% | -39.47% | -39.10% |
| Total Revenue | 26.37% | -13.67% | -37.53% | -40.08% | -39.43% |
| Cost of Revenue | -6.03% | -19.73% | -29.86% | -25.47% | -21.30% |
| Gross Profit | 364.59% | 19.04% | -59.17% | -77.82% | -82.21% |
| SG&A Expenses | 22.24% | 31.00% | 37.58% | 57.99% | 59.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 534.38% | 82.67% | 729.69% | -735.28% | -458.10% |
| Total Operating Expenses | 21.27% | -2.04% | -6.93% | -12.81% | -9.70% |
| Operating Income | -5.85% | -46.80% | -12,473.56% | -476.65% | -286.44% |
| Income Before Tax | -19.02% | -13.45% | 79.65% | 28.09% | -44.94% |
| Income Tax Expenses | 212.73% | 13.99% | -32.13% | 5.24% | 9.00% |
| Earnings from Continuing Operations | -19.17% | -13.45% | 79.62% | 28.07% | -44.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -19.17% | -13.45% | 79.62% | 28.07% | -44.90% |
| EBIT | -5.85% | -46.80% | -12,473.56% | -476.65% | -286.44% |
| EBITDA | -170.14% | -1,385.19% | -179.06% | -128.19% | -112.51% |
| EPS Basic | -76.94% | 85.82% | 98.29% | 67.91% | 42.90% |
| Normalized Basic EPS | 12.25% | 47.75% | 91.05% | 61.79% | 21.41% |
| EPS Diluted | -84.58% | 83.14% | 95.22% | 68.75% | 44.78% |
| Normalized Diluted EPS | 4.59% | 42.56% | 87.17% | 62.30% | 22.82% |
| Average Basic Shares Outstanding | 4.43% | 17.09% | 26.11% | 15.72% | 4.66% |
| Average Diluted Shares Outstanding | 16.20% | 30.37% | 33.66% | 10.48% | 0.26% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |